PARSIPPANY, N.J.--(BUSINESS WIRE)--Ferring Pharmaceuticals today announced the final 60-month follow-up data from the Phase 3 study of ADSTILADRIN ® (nadofaragene firadenovec-vncg) were presented at ...
RICHMOND, Va. -- The Doctor Is In and you have questions. Living with bladder issues can impact your sleep, emotional well-being, and overall quality of life. Dr. Linda Burkett is a Urogynecologist ...
Adstiladrin represents the first gene therapy approved by the FDA for the treatment of patients with high-risk non-muscle invasive bladder cancer who are resistant to BCG, the first-line standard of ...
However, more than 50% of patients who receive initial treatment with BCG will experience disease recurrence and progression within one year, with many developing BCG-unresponsive disease. 2 Current ...
Dear D.J.: The initial treatment for OAB symptoms usually consists of lifestyle changes (i.e., quitting smoking, avoiding medications that worsen symptoms and excess fluid intake at night), pelvic ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window WASHINGTON -- ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved a gene therapy treatment for adult patients with high-risk bacillus Calmette-Guérin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback